Sepsis Diagnostics Market Size Worth USD 1371.18 Million by 2034 | CAGR: 7.9%

The sepsis diagnostics market size is expected to reach USD 1,371.18 million by 2034, according to a new study by Polaris Market Research. The report “Sepsis Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Product (Instrument, Blood Culture Media, Assay Kits & Reagents, and Software), By Technology, By Testing Type, By End User, By Pathogen, and By Region  – Market Forecast, 2026–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The sepsis diagnostics market is growing steadily. This growth is fueled by the rising prevalence of sepsis and growing awareness of early detection. Advancements in diagnostic technologies also support this trend. There is a strong need for rapid and accurate testing, especially in emergency and critical care settings. The adoption of molecular diagnostics and point-of-care testing is also increasing.

Opportunities are emerging in developing countries. The expansion of healthcare infrastructure and the increased availability of sophisticated diagnostic tools are driving market expansion.

New trends such as artificial intelligence, biomarker-based testing, and multiplex assays are improving diagnostic accuracy and speed. There is also a increasing focus on antimicrobial stewardship and personalized treatment. Therefore, these factors are expected to keep driving the demand for new solutions that improve patient outcomes and lower healthcare costs.

Sepsis Diagnostics Market Report Highlights

• North America dominated the sepsis diagnostics market, accounting for 49.80% of revenue in 2025. The area's healthcare system is well-developed, with a strong emphasis on awareness and the early integration of diagnostic tools.
• The Asia Pacific sepsis diagnostics market is expected to grow at a CAGR of 8.2% during the forecast period. This growth is supported by rising healthcare spending, improving diagnostic infrastructure, and a growing patient population.
• In terms of product, the assay kits and reagents segment dominated the market, accounting for the largest share, and is projected to grow at a CAGR of 8.7% during 2026–2034. This is due to their important role in routine sepsis testing and rising demand for rapid diagnostics.
• Based on testing type, the laboratory testing segment held the largest market share in 2025. It offers accurate and detailed results using established diagnostic methods. Point-of-care testing is increasing faster as it delivers quick results and supports timely treatment decisions.
• The global market is dominated by several key players. These include Thermo Fisher Scientific, Abbott Laboratories, BioMérieux, Danaher Corporation, Roche Diagnostics, Siemens Healthineers, BD, QIAGEN, Sysmex Corporation, Beckman Coulter, Hologic, LumiraDx, Cepheid, ACON Laboratories, and Vericel Corporation.

Where is the Market Headed?

The sepsis diagnostics market is shifting toward faster and more accurate testing solutions. Growth is driven by rising use of molecular diagnostics and point-of-care testing. Companies are focusing on tools that help early diagnosis and quick clinical decisions. Integration with software and data systems is enhancing workflow efficiency. Sepsis diagnostics are becoming essential for better patient outcomes and long-term market growth.

What Does Sepsis Diagnostics Market Report Reveals?

• Who are the key industry players? What is their relative position in terms of competitive positioning?
• What is the global market size and CAGR for the market during 2026-2034?
• What factors are contributing largely to the industry expansion?
• How does the market differ in terms of product, technology, testing type, end user, pathogen, and geography? Which segment is leading?
• What are the opportunities across regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa?
• What new technologies and developments are shaping the market?
• How do different end users like hospitals, labs, and research institutes affect the market?

Request a free sample copy or read the full market insights: Sepsis Diagnostics Market Report

Polaris Market Research has segmented the sepsis diagnostics market report on the basis of product, technology, testing type, end user, pathogen, and region:

By Product Outlook (Revenue – USD Million, 2021–2034)

• Instrument
• Blood Culture Media
• Assay Kits & Reagents
• Software

By Technology Outlook (Revenue – USD Million, 2021–2034)

• Microbiology
• Molecular Diagnostics
• Immunoassays
• Flow Cytometry
• Others

By Testing Type Outlook (Revenue – USD Million, 2021–2034)

• Laboratory Testing
• Point-of-Care Testing

By End User Outlook (Revenue – USD Million, 2021–2034)

• Hospitals & Clinics
• Pathology & Reference Laboratories
• Research Institutes
• Others

By Pathogen Outlook (Revenue – USD Million, 2021–2034)

• Bacterial Sepsis
  • Gram Positive Bacteria
  • Gram Negative Bacteria
• Fungal Sepsis
• Others

By Regional Outlook (Revenue – USD Million, 2021–2034)

• North America

  • US
  • Canada

• Europe

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe

• Asia Pacific

  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific

• Middle East & Africa

  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa

• Latin America

  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America